MILPITAS, Calif. -
May 15, 2018 -
PRLog -- Alpha-Galactosidase -α-Gal; EC 3.2.1.22 hydrolyzes alpha-galactosyl moieties found in glycolipids and glycoproteins. In mammals, α-Gal hydrolyzes poly- and oligosaccharides commonly found in dietary sources that are difficult to digest. Therefore, α-Gal is used in dietary supplements that help to reduce the production of intestinal gases due to consumption of certain foods. It is known total α-Gal activity is due to two major isozymes with unique, yet different thermostability profiles. Alpha-Galactosidase A, is thermolabile and represents approximately 90% of total α-Gal activity. Fabry Disease, a lysosomal disease disorder, is characterized by mutations in alpha-Galactosidase A. These mutations cause abnormal accumulation of glycosphingolipids in lysosomes. BioVision's Alpha Galactosidase Activity Assay Kit provides a simple, rapid way to monitor total α-Gal activity in wide variety of biological samples. In this kit, α-Gal cleaves a synthetic specific substrate releasing a fluorophore, which can be easily quantified (Ex/Em= 360/445 nm). The assay is specific, sensitive and can detect as low as 0.1 µU of α-Galactosidase activity.
Figure: α-Galactosidase Activity in Mouse Kidney Tissue Extracts (1 µg protein) and U937 Cell Lysates (0.2 µg protein) using K407-100.
For detailed information on this products, visit:
https://www.biovision.com/alpha-galactosidase-gal-activit...
